Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Rose

Showing results (171-180 of 177) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 177 results.
Rheumatology (Oxford, England)|February 3, 2026
The development of a risk threshold to aid risk stratified approach to monitoring for haematological, hepatic and/or renal adverse drug reactions during established conventional synthetic DMARD treatment for systemic autoimmune rheumatic diseases: a RAND/UCLA Appropriateness Method consensus studyJoanne Ablewhite, Georgina Nakafero, Abdullah Almayahi, et al.
Cancer Discovery|December 6, 2011
Characterization of KRAS rearrangements in metastatic prostate cancerXiao-Song Wang, Sunita Shankar, Saravana M Dhanasekaran, et al.
Rheumatology Advances in Practice|October 15, 2025
Biologic and targeted synthetic DMARD safety in inflammatory arthritis: British Society for Rheumatology guideline scopeStephanie F Ling, Joshua L Bennett, Vanessa J Reid, et al.
Rheumatology Advances in Practice|July 15, 2024
The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scopeLouise Mercer, Abhishek Abhishek, Akhila Kavirayani, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 29, 2021
Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXASMarcela A Ferrada, Keith A Sikora, Yiming Luo, et al.
Rheumatology (Oxford, England)|November 14, 2025
The 2025 British Society for Rheumatology guideline for the prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugsKatie Bechman, Kaiyang Song, Abhishek Abhishek, et al.
American Journal of Human Genetics|September 2, 2022
Identification and single-base gene-editing functional validation of a cis-EPO variant as a genetic predictor for EPO-increasing therapiesCharli E Harlow, Josan Gandawijaya, Rosemary A Bamford, et al.
Pageof 18

Showing results (171-180 of 177) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 177 results.
Rheumatology (Oxford, England)|February 3, 2026
The development of a risk threshold to aid risk stratified approach to monitoring for haematological, hepatic and/or renal adverse drug reactions during established conventional synthetic DMARD treatment for systemic autoimmune rheumatic diseases: a RAND/UCLA Appropriateness Method consensus studyJoanne Ablewhite, Georgina Nakafero, Abdullah Almayahi, et al.
Cancer Discovery|December 6, 2011
Characterization of KRAS rearrangements in metastatic prostate cancerXiao-Song Wang, Sunita Shankar, Saravana M Dhanasekaran, et al.
Rheumatology Advances in Practice|October 15, 2025
Biologic and targeted synthetic DMARD safety in inflammatory arthritis: British Society for Rheumatology guideline scopeStephanie F Ling, Joshua L Bennett, Vanessa J Reid, et al.
Rheumatology Advances in Practice|July 15, 2024
The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scopeLouise Mercer, Abhishek Abhishek, Akhila Kavirayani, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 29, 2021
Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXASMarcela A Ferrada, Keith A Sikora, Yiming Luo, et al.
Rheumatology (Oxford, England)|November 14, 2025
The 2025 British Society for Rheumatology guideline for the prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugsKatie Bechman, Kaiyang Song, Abhishek Abhishek, et al.
American Journal of Human Genetics|September 2, 2022
Identification and single-base gene-editing functional validation of a cis-EPO variant as a genetic predictor for EPO-increasing therapiesCharli E Harlow, Josan Gandawijaya, Rosemary A Bamford, et al.
Pageof 18